125 related articles for article (PubMed ID: 568626)
1. Formation and utilization of novel high energy phosphate reservoirs in Ehrlich ascites tumor cells. Cyclocreatine-3-P and creatine-P.
Annesley TM; Walker JB
J Biol Chem; 1978 Nov; 253(22):8120-5. PubMed ID: 568626
[No Abstract] [Full Text] [Related]
2. Cyclocreatine phosphate as a substitute for creatine phosphate in vertebrate tissues. Energistic considerations.
Annesley TM; Walker JB
Biochem Biophys Res Commun; 1977 Jan; 74(1):185-90. PubMed ID: 836276
[No Abstract] [Full Text] [Related]
3. Conversion of dietary N-Ethylguanidinoacetate by Ehrlich ascites tumor cells and animal tissues to a functionally active analog of creatine phosphate.
Roberts JJ; Walker JB
Arch Biochem Biophys; 1982 May; 215(2):564-70. PubMed ID: 7092241
[No Abstract] [Full Text] [Related]
4. Phosphocreatine in Ehrlich ascites tumor cells detected by noninvasive 31P NMR spectroscopy.
Yushok WD; Gupta RK
Biochem Biophys Res Commun; 1980 Jul; 95(1):73-81. PubMed ID: 7417272
[No Abstract] [Full Text] [Related]
5. Accumulation of analgo of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine).
Griffiths GR; Walker JB
J Biol Chem; 1976 Apr; 251(7):2049-54. PubMed ID: 1270421
[TBL] [Abstract][Full Text] [Related]
6. Formation of a supplemental long time-constant reservoir of high energy phosphate by brain in vivo and in vitro and its reversible depletion by potassium depolarization.
Woznicki DT; Walker JB
J Neurochem; 1979 Jul; 33(1):75-80. PubMed ID: 458473
[No Abstract] [Full Text] [Related]
7. Utilization of cyclocreatine phosphate, and analogue of creatine phosphate, by mouse brain during ischemia and its sparing action on brain energy reserves.
Woznicki DT; Walker JB
J Neurochem; 1980 May; 34(5):1247-53. PubMed ID: 7373304
[No Abstract] [Full Text] [Related]
8. Synthesis and accumulation of an extremely stable high-energy phosphate compound by muscle, heart, and brain of animals fed the creatine analog, 1-carboxyethyl-2-iminoimidazolidine (homocyclocreatine).
Roberts JJ; Walker JB
Arch Biochem Biophys; 1983 Feb; 220(2):563-71. PubMed ID: 6824340
[TBL] [Abstract][Full Text] [Related]
9. Investigations on the function of creatine kinase in Ehrlich ascites tumor cells.
Becker S; Schneider F
Biol Chem Hoppe Seyler; 1989 Apr; 370(4):357-64. PubMed ID: 2757796
[TBL] [Abstract][Full Text] [Related]
10. Cyclocreatine phosphate, an analogue of creatine phosphate, does not improve hypoxic tolerance in mice.
Artru AA; Michenfelder JD
J Neurochem; 1982 Oct; 39(4):1198-200. PubMed ID: 7119791
[TBL] [Abstract][Full Text] [Related]
11. Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
Bergnes G; Yuan W; Khandekar VS; O'Keefe MM; Martin KJ; Teicher BA; Kaddurah-Daouk R
Oncol Res; 1996; 8(3):121-30. PubMed ID: 8823808
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway.
Kurmi K; Hitosugi S; Yu J; Boakye-Agyeman F; Wiese EK; Larson TR; Dai Q; Machida YJ; Lou Z; Wang L; Boughey JC; Kaufmann SH; Goetz MP; Karnitz LM; Hitosugi T
Cell Metab; 2018 Dec; 28(6):833-847.e8. PubMed ID: 30174304
[TBL] [Abstract][Full Text] [Related]
13. Enhanced ability of skeletal muscle containing cyclocreatine phosphate to sustain ATP levels during ischemia following beta-adrenergic stimulation.
Turner DM; Walker JB
J Biol Chem; 1987 May; 262(14):6605-9. PubMed ID: 3571272
[TBL] [Abstract][Full Text] [Related]
14. Energy metabolism of skeletal muscle containing cyclocreatine phosphate. Delay in onset of rigor mortis and decreased glycogenolysis in response to ischemia or epinephrine.
Annesley TM; Walker JB
J Biol Chem; 1980 May; 255(9):3924-30. PubMed ID: 7372660
[No Abstract] [Full Text] [Related]
15. Protective effect of creatine against inhibition by methylglyoxal of mitochondrial respiration of cardiac cells.
Roy SS; Biswas S; Ray M; Ray S
Biochem J; 2003 Jun; 372(Pt 2):661-9. PubMed ID: 12605598
[TBL] [Abstract][Full Text] [Related]
16. The effect of potassium depletion on the initial kinetics of glycolysis in ascites tumor cells.
Greenhouse WV; Coe EL
Biochim Biophys Acta; 1973 Dec; 329(2):183-95. PubMed ID: 4271972
[No Abstract] [Full Text] [Related]
17. The uptake of creatine by various tissues from a mouse bearing tumor cells.
Yanokura M; Sawai Y; Tsukada K
Biochim Biophys Acta; 1984 Jan; 797(1):94-8. PubMed ID: 6692010
[TBL] [Abstract][Full Text] [Related]
18. [NMR spectroscopy of tumors. Effects of subpopulation replacement in a growing tumor].
Semenova NA; Dubinskiĭ VZ
Dokl Akad Nauk; 1992; 323(1):169-72. PubMed ID: 1638957
[No Abstract] [Full Text] [Related]
19. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Lillie JW; O'Keefe M; Valinski H; Hamlin HA; Varban ML; Kaddurah-Daouk R
Cancer Res; 1993 Jul; 53(13):3172-8. PubMed ID: 8319226
[TBL] [Abstract][Full Text] [Related]
20. A possible role of the creatine phosphate-creatine pool in the regulation of the adenylate pool.
Pezzini A; Conte A; Galbani P; Ronca-Testoni S
Int J Tissue React; 1988; 10(2):107-10. PubMed ID: 3182186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
